Dermata Therapeutics Inc (DRMA)
1.120
-0.07
(-5.79%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics Total Liabilities (Quarterly): 1.918M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.918M |
| March 31, 2024 | 1.372M |
| December 31, 2023 | 1.624M |
| September 30, 2023 | 0.9168M |
| June 30, 2023 | 0.6829M |
| March 31, 2023 | 1.207M |
| December 31, 2022 | 0.9226M |
| September 30, 2022 | 1.504M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.366M |
| March 31, 2022 | 1.192M |
| December 31, 2021 | 1.517M |
| September 30, 2021 | 1.195M |
| June 30, 2021 | 1.643M |
| March 31, 2021 | 0.9392M |
| December 31, 2020 | 3.783M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6829M
Minimum
Jun 2023
3.783M
Maximum
Dec 2020
1.452M
Average
1.366M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 9.193M |
| Cognition Therapeutics Inc | 11.36M |
| ZyVersa Therapeutics Inc | 10.85M |
| Bone Biologics Corp | 0.2845M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.237M |
| Shareholders Equity (Quarterly) | 3.318M |